Compare INNIO N.V. Ordinary Shares (INIO) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
INNIO N.V. Ordinary Shares vs Kymera Therapeutics Inc. Common Stock — how do they compare? INNIO N.V. Ordinary Shares trades at $16 (market cap $13.73B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: INNIO N.V. Ordinary Shares is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, INNIO N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold INNIO N.V. Ordinary Shares for 0 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| INIO | KYMR | |
|---|---|---|
Market Cap | $13.73B | $8.87B |
Volume | 5,012,195 | 779,107 |
Sector | Industrials | Health |
52-Week High | $41.13 | $127.31 |
52-Week Low | $16.50 | $55.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $15.39B | $8.26B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About INNIO N.V. Ordinary Shares
INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
